- Home
- BDSX vs TSVT Comparison
BDSX vs TSVT Comparison
Compare BDSX & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- TSVT
- Stock Information
- Founded
- BDSX 2005
- TSVT 2021
- Country
- BDSX United States
- TSVT United States
- Employees
- BDSX N/A
- TSVT N/A
- Industry
- BDSX Precision Instruments
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- BDSX Health Care
- TSVT Health Care
- Exchange
- BDSX Nasdaq
- TSVT Nasdaq
- Market Cap
- BDSX 245.3M
- TSVT 253.9M
- IPO Year
- BDSX 2020
- TSVT N/A
- Fundamental
- Price
- BDSX $1.63
- TSVT $4.76
- Analyst Decision
- BDSX Strong Buy
- TSVT Buy
- Analyst Count
- BDSX 4
- TSVT 6
- Target Price
- BDSX $3.08
- TSVT $10.40
- AVG Volume (30 Days)
- BDSX 243.1K
- TSVT 318.2K
- Earning Date
- BDSX 11-05-2024
- TSVT 11-12-2024
- Dividend Yield
- BDSX N/A
- TSVT N/A
- EPS Growth
- BDSX N/A
- TSVT N/A
- EPS
- BDSX N/A
- TSVT N/A
- Revenue
- BDSX $60,902,000.00
- TSVT $44,120,000.00
- Revenue This Year
- BDSX $48.06
- TSVT N/A
- Revenue Next Year
- BDSX $29.97
- TSVT $22.42
- P/E Ratio
- BDSX N/A
- TSVT N/A
- Revenue Growth
- BDSX 46.25
- TSVT N/A
- 52 Week Low
- BDSX $1.15
- TSVT $1.54
- 52 Week High
- BDSX $2.21
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- BDSX 39.68
- TSVT 50.57
- Support Level
- BDSX $1.65
- TSVT $4.60
- Resistance Level
- BDSX $1.71
- TSVT $4.90
- Average True Range (ATR)
- BDSX 0.08
- TSVT 0.32
- MACD
- BDSX -0.01
- TSVT -0.00
- Stochastic Oscillator
- BDSX 19.23
- TSVT 59.09
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.